CEBAM | ACP | HAS | KDIGO | KHA-CARI | BCMA | UMHS | VA-DoD | NICE | ||
---|---|---|---|---|---|---|---|---|---|---|
2012 | 2013 | 2013 | 2013 | 2013 | 2014 | 2014 | 2014 | 2015 | ||
Management of anemia | ||||||||||
diagnosis | definition | ▪ | ▪ | ▪ | ▪ | |||||
lower limit in g/dl | 11 | M: 13, F: 12 | M: 13, F: 12 | 11 | ||||||
monitoring | monitor for anemia | ▪ | ▪ | ▪ | i | ▪ | ||||
tests | ▪ | ▪ | ▪ | |||||||
frequency (per year) | individual | 1–4 | ||||||||
initial evaluation | ▪ | |||||||||
treatment options | iron | ▪ | i | ▪ | ||||||
erythropoetin | ▪ | i | ||||||||
nutritional supplements | i | |||||||||
androgens | ||||||||||
blood transfusion | −/i* | |||||||||
treatment | indications | ▪ | ||||||||
target values | ▪ | |||||||||
monitoring | ▪ | |||||||||
erythropoietine resistance | ▪ | |||||||||
referral | ▪ |